Sartorius Stedim Biotech Detailed Consensus
Consensus as of: 2025-05-26

KPI[EUR m]Q2 2024FY 2024Q2 2025 EFY 2025 EFY 2026 EFY 2028 EFY 2023-2028 CAGR E
Sales revenueNumber of Estimates9131312-
Sales revenueHighest762.93,030.83,379.74,249.5-
Sales revenueConsensus (Mean)706.42,780.0747.22,996.13,319.34,141.1-
Sales revenueMedian748.93,002.43,313.04,126.1-
Sales revenueLowest735.02,943.43,250.23,888.2-
Sales revenue growth in constant currencies in %Number of Estimates91010107
Sales revenue growth in constant currencies in %Highest10.610.112.613.610.8
Sales revenue growth in constant currencies in %Consensus (Mean)8.10.67.18.611.311.88.9
Sales revenue growth in constant currencies in %Median6.68.712.011.88.8
Sales revenue growth in constant currencies in %Lowest4.96.09.09.07.0
Underlying EBITDANumber of Estimates9131312-
Underlying EBITDAHighest233.5928.91,079.01,469.4-
Underlying EBITDAConsensus (Mean)196.3779.0225.6911.91,043.41,389.0-
Underlying EBITDAMedian224.0912.51,051.01,399.8-
Underlying EBITDALowest215.6895.4968.21,200.4-
Underlying EBITDA margin in %Number of Estimates9131312-
Underlying EBITDA margin in %Highest31.031.132.534.7-
Underlying EBITDA margin in %Consensus (Mean)27.828.030.030.431.433.5-
Underlying EBITDA margin in %Median30.430.431.533.8-
Underlying EBITDA margin in %Lowest28.029.829.630.9-
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.